Back
Speaker illustration

Doctor Yale Mitchel

Rahway (United States of America)

Presentations

Anacetrapib decreases LDL-C in patients with heterozygous familial hypercholesterolemia irrespective of the underlying genetic mutation

Event: ESC Congress 2017

Topic: Lipids (Epidemiology and Prevention)

Session: Lipids

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources